Recovery of Spermatogenesis Following Cancer Treatment with Cytotoxic Chemotherapy and Radiotherapy
- Author:
Keisuke OKADA
1
;
Masato FUJISAWA
Author Information
- Publication Type:Review
- Keywords: Drug therapy; Infertility, male; Radiation; Spermatogenesis
- MeSH: Alkylating Agents; Cryopreservation; Drug Therapy; Embryonic Stem Cells; Fertility; Fertility Preservation; Germ Cells; Gonads; Hope; Humans; Induced Pluripotent Stem Cells; Infertility; Infertility, Male; Male; Methods; Quality of Life; Radiotherapy; Spermatogenesis; Spermatozoa; Stem Cells; Survival Rate; Whole-Body Irradiation
- From:The World Journal of Men's Health 2019;37(2):166-174
- CountryRepublic of Korea
- Language:English
- Abstract: The survival rates of boys and men with cancer have increased due to advances in cancer treatments; however, maintenance of quality of life, including fertility preservation, remains a major issue. Fertile male patients who receive radiation and/or chemotherapy face temporary, long-term, or permanent gonadal damage, particularly with exposure to alkylating agents and whole-body irradiation, which sometimes induce critical germ cell damage. These cytotoxic treatments have a significant impact on a patient's ability to have their own biological offspring, which is of particular concern to cancer patients of reproductive age. Therefore, various strategies are needed in order to preserve male fertility. Sperm cryopreservation is an effective method for preserving spermatozoa. Advances have also been achieved in pre-pubertal germ cell storage and research to generate differentiated male germ cells from various types of stem cells, including embryonic stem cells, induced pluripotent stem cells, and spermatogonial stem cells. These approaches offer hope to many patients in whom germ cell loss is associated with sterility, but are still experimental and preliminary. This review examines the current understanding of the effects of chemotherapy and radiation on male fertility.
